Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. J Clin Oncol. 2008 May 20; 26(15):2457-63.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Combined Modality Therapy
Deoxycytidine
Female
Follow-Up Studies
Humans
Lung Neoplasms
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Staging
Paclitaxel
Placebos
Prognosis
Radiography
Radiotherapy Dosage
Radiotherapy, Conformal
Remission Induction
Survival Rate
Thoracic Neoplasms

authors with profiles

Everett E. Vokes